Bavarian Nordic to supply its smallpox vaccine to EU country  

2009.09.21
The Danish vaccine company has announced that it has signed a contract with the armed forces of an undisclosed EU country to supply its smallpox vaccine
Danish vaccine company Bavarian Nordic has announced in a press release that it has signed a contract with the armed forces of an undisclosed EU country to supply its smallpox vaccine Imvamune. The order, of undisclosed  value and described as 'small', will be delivered in 2009. This is the first time that the company has contracted to supply the vaccine to an EU country.

Bavarian Nordic's CEO Anders Hedegaard writes: "Entering the first contract with an EU country on Imvamune demonstrates the need for new and safer smallpox vaccines. We have a continued ongoing positive dialogue with governments in and outside the EU, and we expect that this will lead to several smaller contracts."
 
Hedegaard goes on to say that when an expected 20 million dose order from the US government is received, this will send 'an important message to other governments' who are considering stockpiling Imvamune. The US order is currently awaiting approval from the Food and Drug Administration (FDA).

Headquartered in Denmark, Bavarian Nordic develops and produces innovative vaccines to prevent and treat life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases. Bavarian Nordic employs over 260 people and has operations in Germany, the US and Singapore. Bavarian Nordic's partners include Impfstoffwerk Dessau-Tornau (IDT) and Vaccine Solutions.
 
Link > Bavarian Nordic                                

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×